✦ LIBER ✦

Glucose tolerance as a predictor of surgical risk and survival in patients with pancreatic carcinoma

✍ Scribed by Kazue Ozawa; Mamoru Sato; Takayoshi Tobe

Book ID: 115692965
Publisher: Elsevier Science
Year: 1980
Tongue: English
Weight: 596 KB
Volume: 139
Category: Article
ISSN: 0002-9610
DOI: 10.1016/0002-9610(80)90292-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pain as a predictor of outcome in patien

Pain as a predictor of outcome in patients with operable pancreatic carcinoma

✍ David P Kelsen; Russell Portenoy; Howard Thaler; Yue Tao; Murray Brennan 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 639 KB

Patient Satisfaction with Quality of Lif

Patient Satisfaction with Quality of Life as a Predictor of Survival in Pancreatic Cancer

✍ Lis, Christopher G. ;Gupta, Digant ;Grutsch, James F. 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 158 KB

A prospective study of glucose tolerance

A prospective study of glucose tolerance, insulin, C-peptide, and glucagon responses in patients with pancreatic carcinoma

✍ Schwartz, Stanley S. ;Zeidler, Adina ;Moossa, A. R. ;Kuku, Sonny F. ;Rubenstein, 📂 Article 📅 1978 🏛 Springer-Verlag ⚖ 598 KB

L1 expression as a predictor of progress

L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas

✍ Mina Fogel; Paul Gutwein; Sabine Mechtersheimer; Svenja Riedle; Alexander Stoeck 📂 Article 📅 2003 🏛 The Lancet 🌐 English ⚖ 688 KB

Quality of life as a survival predictor

Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy

✍ Fu-Min Fang; Yi-Tien Liu; Yeh Tang; Chong-Jong Wang; Sheung-Fat Ko 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 1 views

## Abstract ## BACKGROUND Accumulating reports suggest that quality of life (QoL) may predict survival in patients with malignant disease. In the current study, the authors investigated if baseline QoL and changes in QoL during treatment were prognostic for patients with advanced head and neck squ

Plasma matrix metalloproteinase-7 as a m

Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomas

✍ Azizbek Ramankulov; Michael Lein; Manfred Johannsen; Mark Schrader; Kurt Miller; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB